Alivus Life Sciences’ promoter Nirma has sold 2.31% stake in the company through open market transactions worth around Rs 389.94 crore. Nirma has offloaded around 28.46 lakh shares of the company at an average price of Rs 1,370.00 apiece.
Meanwhile, a group of Mutual Funds and institutional investors bought equal number of shares at the same price. Bandhan Mutual Fund was emerged as the largest buyer, acquiring 7.30 lakh shares worth around Rs 99.97 crore.
Alivus Life Sciences (formerly Glenmark Life Sciences) is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease (CVS), central nervous system disease (CNS), pain management and diabetes.